InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
0
T+90 hit rate
57%
T+90 mean return
-5.3%
Across 37 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by ARCH Venture Partners IX, LLC. Officer active across 3 companies, notably Lyell Immunopharma, Inc.. In total, 37 disclosures have been published. Activity tracked since 22 June 2021. The latest transaction was disclosed on 2 September 2022 (J). Regulator: SEC (Form 4). All data is free.
Declarations37 total
196,003 shares0Common StockSEC:0001062993-22-019342:0
217,781 shares0Common StockSEC:0001062993-22-018984:0
217,781 shares0Common StockSEC:0001062993-22-018811:0
217,781 shares0Common StockSEC:0001062993-22-018573:0
282,219 shares0Common StockSEC:0001062993-22-018154:1
13,076 shares0Common StockSEC:0001062993-22-018154:2
1,475 shares0Common StockSEC:0001062993-22-018154:3
2,952 shares0Common StockSEC:0001062993-22-018154:4
217,781 shares0Common StockSEC:0001062993-22-018154:5
282,219 shares0Common StockSEC:0001062993-22-018154:6
13,076 shares0Common StockSEC:0001062993-22-018154:7
1,475 shares0Common StockSEC:0001062993-22-018154:8
2,952 shares0Common StockSEC:0001062993-22-018154:9
217,781 shares0Common StockSEC:0001062993-22-018154:10
282,219 shares0Common StockSEC:0001062993-22-018154:11
13,076 shares0Common StockSEC:0001062993-22-018154:12
1,475 shares0Common StockSEC:0001062993-22-018154:13
2,952 shares0Common StockSEC:0001062993-22-018154:14
217,781 shares0Common StockSEC:0001062993-22-018154:0
217,781 shares0Common StockSEC:0001062993-22-014696:0
217,781 shares0Common StockSEC:0001062993-22-014426:0
762,233 shares0Common StockSEC:0001062993-21-013385
762,233 shares0Common StockSEC:0001062993-21-013385:0
217,781 shares0Common StockSEC:0001062993-21-011917:0
217,781 shares0Common StockSEC:0001062993-21-011917
25 of 37 declarations
About ARCH Venture Partners IX, LLC
ARCH Venture Partners IX, LLC is an investor in Lyell Immunopharma, Inc.
